Clinical Trials Directory

Trials / Completed

CompletedNCT04055662

A Comparison of Post-Operative Analgesia Requirements In Recreational Cannabis Users Versus Cannabis Naïve Inflammatory Bowel Disease Patients

A Comparison of Post-Operative Analgesia Requirements In Recreational Cannabis Users

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Mount Sinai Hospital, Canada · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers

Summary

Cannabis is a drug that is widely used for recreational purpose. In most patients undergoing surgery, opioids are the most widely used mode of pain relief, during and following surgery. Anecdotally it has been observed that cannabis users required unexpectedly high doses of opioids. The purpose of this study is to compare opioid requirements between cannabis users and non- users after the surgery. Currently, post-operative opioid doses are determined based on various patient factors such as pre-operative opioid use, patient weight, age and sensitivity to opioids during surgery. Patients' requirements may be underestimated and opioid regimens need to be escalated in the first 24 hours in order to alleviate uncontrolled pain in cannabis users. Better understanding of the impacts of cannabis use on post-operative opioid requirements would help the Acute Pain Service optimize post-operative pain management for patients who use cannabis pre-operatively.

Conditions

Timeline

Start date
2019-08-01
Primary completion
2020-03-30
Completion
2020-03-30
First posted
2019-08-14
Last updated
2022-04-11

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04055662. Inclusion in this directory is not an endorsement.